|
|
|
Insider
Information: |
Berman Richard J |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
11 |
|
Direct
Shares |
4,922,506 |
|
Indirect Shares
|
31,250 |
|
|
Direct
Value |
$1,221,760 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
4,953,756 |
|
|
Total
Value |
$1,221,760 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
11
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
10
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-596.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Seelos Therapeutics Inc |
SEEL |
Director |
2010-06-30 |
23,965 |
2003-08-27 |
0 |
Premium* |
|
EasyLink Services International ... |
ESIC |
Director |
2012-07-02 |
0 |
2012-07-02 |
0 |
Premium* |
|
Advaxis Inc |
ADXS |
Director |
2018-06-26 |
55,669 |
2005-12-31 |
0 |
Premium* |
|
Lisata Therapeutics Ord Shs |
LSTA |
Director |
2017-01-09 |
7,177 |
|
0 |
Premium* |
|
Superfly Advertising Inc |
SPFL |
Officer, Director, 10%... |
2008-02-14 |
3,162,788 |
|
0 |
Premium* |
|
Metastat Inc |
MTST |
|
2017-04-04 |
52,696 |
|
0 |
Premium* |
|
Lustros Inc |
LSTS |
Director |
2013-06-12 |
1,000,000 |
2013-06-12 |
0 |
Premium* |
|
Cryoport Inc |
CYRX |
Director |
2024-05-17 |
112,845 |
2022-12-01 |
0 |
Premium* |
|
COMSovereign Holding Corp |
COMS |
Director |
2021-01-21 |
438,131 |
|
0 |
Premium* |
|
Frontier Investment Corp |
FICV |
Director |
|
0 |
2021-06-30 |
31,250 |
Premium* |
|
Biovie Inc. |
BIVI |
Director |
2023-11-09 |
69,235 |
2020-01-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SEEL |
Seelos Therapeutics Inc |
Director |
|
2005-04-04 |
4 |
B |
$1.11 |
$11,104 |
D/D |
10,000 |
36,002 |
2.39 |
- |
|
ESIC |
EasyLink Services Interna... |
Director |
|
2005-11-23 |
5 |
S |
$2.90 |
$11,600 |
D/D |
(4,000) |
199,310 |
0 |
- |
|
ADXS |
Advaxis Inc |
Director |
|
2007-02-23 |
4 |
A |
$0.50 |
$12,000 |
D/D |
24,000 |
76,000 |
0 |
- |
|
ADXS |
Advaxis Inc |
Director |
|
2005-12-31 |
4 |
A |
$0.50 |
$14,000 |
D/D |
28,000 |
28,000 |
|
- |
|
CYRX |
Cryoport Inc |
Director |
|
2019-11-13 |
4 |
OE |
$3.07 |
$15,350 |
D/D |
5,000 |
5,000 |
0 |
- |
|
CYRX |
Cryoport Inc |
Director |
|
2019-11-15 |
4 |
OE |
$3.07 |
$15,350 |
D/D |
5,000 |
5,000 |
0 |
- |
|
CYRX |
Cryoport Inc |
Director |
|
2015-12-31 |
4 |
A |
$2.03 |
$16,666 |
D/D |
8,210 |
21,396 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2005-04-05 |
4 |
B |
$1.12 |
$16,829 |
D/D |
15,000 |
51,002 |
2.39 |
- |
|
CYRX |
Cryoport Inc |
Director |
|
2015-03-31 |
4 |
A |
$8.28 |
$20,120 |
D/D |
2,430 |
2,430 |
0 |
- |
|
CYRX |
Cryoport Inc |
Director |
|
2015-06-30 |
4 |
A |
$7.62 |
$20,124 |
D/D |
2,641 |
5,071 |
0 |
- |
|
CYRX |
Cryoport Inc |
Director |
|
2015-09-30 |
4 |
A |
$2.48 |
$20,125 |
D/D |
8,115 |
13,186 |
0 |
- |
|
CYRX |
Cryoport Inc |
Director |
|
2018-05-25 |
4 |
S |
$11.91 |
$23,825 |
I/I |
(2,000) |
6,138 |
0 |
- |
|
LSTA |
Lisata Therapeutics Ord S... |
Director |
|
2012-09-18 |
4 |
S |
$0.69 |
$24,840 |
D/D |
(36,000) |
149,306 |
0 |
- |
|
ESIC |
EasyLink Services Interna... |
Director |
|
2006-02-06 |
5 |
S |
$3.32 |
$27,224 |
D/D |
(8,200) |
189,310 |
0 |
- |
|
BIVI |
Biovie Inc. |
Director |
|
2023-03-27 |
4 |
S |
$8.52 |
$28,711 |
D/D |
(3,371) |
41,807 |
0 |
% |
|
CYRX |
Cryoport Inc |
Director |
|
2020-07-29 |
4 |
OE |
$3.57 |
$29,053 |
I/I |
8,138 |
9,250 |
0 |
- |
|
ESIC |
EasyLink Services Interna... |
Director |
|
2011-07-14 |
4 |
S |
$5.89 |
$29,457 |
D/D |
(5,000) |
48,232 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2009-06-09 |
4 |
A |
$1.47 |
$30,195 |
D/D |
20,541 |
348,493 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2009-10-06 |
4 |
A |
$1.47 |
$30,195 |
D/D |
20,541 |
369,034 |
0 |
- |
|
CYRX |
Cryoport Inc |
Director |
|
2018-09-06 |
4 |
OE |
$3.07 |
$30,700 |
D/D |
10,000 |
10,000 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2010-03-09 |
4 |
S |
$0.50 |
$30,937 |
D/D |
(61,873) |
307,161 |
0 |
- |
|
CYRX |
Cryoport Inc |
Director |
|
2018-11-15 |
4 |
OE |
$3.07 |
$31,314 |
D/D |
10,200 |
10,200 |
0 |
- |
|
BIVI |
Biovie Inc. |
Director |
|
2023-05-22 |
4 |
S |
$6.50 |
$32,506 |
D/D |
(5,000) |
29,194 |
0 |
% |
|
BIVI |
Biovie Inc. |
Director |
|
2023-06-07 |
4 |
S |
$5.81 |
$34,782 |
D/D |
(5,984) |
23,210 |
0 |
% |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2008-01-09 |
4 |
A |
$1.48 |
$36,000 |
D/D |
24,324 |
205,553 |
0 |
- |
|
148 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|